Position history for Temasek Holdings (Private) Ltd's holdings in DENALI THERAPEUTICS INC
Temasek Holdings (Private) Ltd holds 7M shares of DNLI (DENALI THERAPEUTICS INC), worth $115.8M as of 2025-Q4. The position was increased (++30.9% shares). DNLI represents 0.4% of Temasek Holdings (Private) Ltd's portfolio.
Current Value
$115.8M
Current Shares
7M
Total Value Change
-$16.7M
Total Shares Change
+1.3M
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 7M |
+30.9% |
| $115.8M |
| 0.4% |
| $16.41 |
46 |
| 2025-Q3 | Unchanged | 5.4M | 0.0% | $77.8M | 0.3% | $14.52 | 0 |
| 2025-Q2 | Unchanged | 5.4M | 0.0% | $74.9M | 0.3% | $14.10 | 0 |
| 2025-Q1 | Unchanged | 5.4M | 0.0% | $72.8M | 0.3% | $14.78 | 0 |
| 2024-Q4 | Unchanged | 5.4M | 0.0% | $109.2M | 0.4% | $20.24 | 0 |
| 2024-Q3 | Decreased | 5.4M | -6.1% | $156M | 0.6% | $29.43 | 0 |
| 2024-Q2 | Unchanged | 5.7M | 0.0% | $132.5M | 0.6% | $23.22 | 0 |